Big Money Elevating United Therapeutics [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
It also conducts cutting-edge medical research, which could bring longer-term growth opportunities. Additionally, UTHR recently began a partnership to use AI to diagnose unrecognized PAH cases. The company's financial performance is capturing investor attention too. In its March report, the company showed 33.7% revenue growth and a net margin of 45.2%. UTHR also has a low debt-to-equity ratio of just 0.11, reflecting a small use of debt financing and conservative cash management. It's no wonder UTHR shares are up 44% this year – and they could rise more. MAPsignals data shows how Big Money investors are betting heavily on the forward picture of the stock. United Therapeutics Shares in Demand Institutional volumes reveal plenty. Recently, UTHR has enjoyed strong investor demand, which we believe to be institutional support. Each green bar signals unusually large volumes in UTHR shares. They reflect our proprietary inflow signal, pushing the stock higher: Plenty of health ca
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of DirectorsBusiness Wire
- Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension [Yahoo! Finance]Yahoo! Finance
- United Therapeutics Co. (NASDAQ: UTHR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Wells Fargo & Company from $325.00 to $350.00. They now have an "overweight" rating on the stock.MarketBeat
UTHR
Earnings
- 5/1/24 - Beat
UTHR
Sec Filings
- 6/28/24 - Form 4
- 6/28/24 - Form 3
- 6/28/24 - Form 4
- UTHR's page on the SEC website